ClearPoint Neuro(NASDAQ) CLPT

Current Price$14.11

Market Cap$423.45M

Since IPO (2012)-53%

5 Year-30%

1 Year+25%

1 Month-21%

ClearPoint Neuro last closing stock price
Metric	Price	Date
Last close	USD 14.12	2026-07-24

ClearPoint Neuro stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-6.8%	USD 15.15	2026-07-17
1 month	-21.47%	USD 17.98	2026-06-24
3 month	+19.86%	USD 11.78	2026-04-24
Year to date	+3.22%	USD 13.68	2025-12-31
1 year	+25.18%	USD 11.28	2025-07-24
3 year	+116.56%	USD 6.52	2023-07-25
5 year	-29.93%	USD 20.15	2021-07-23
Since inception	-52.93%	USD 30.00	2012-05-21

ClearPoint Neuro Financials at a Glance

Market Cap

$423.45M

Revenue (TTM)

$40.61M

Net Income (TTM)

-$29.07M

EPS (TTM)

-$1.01

P/E Ratio

-14.01

Dividend

$0.00

Beta (Volatility)

1.87 (High)

Dividend

$0.00

Beta (Volatility)

1.87 (High)

Price

$14.11

Volume

467,357.138

Open

$14.61

Price

$14.11

Volume

467,357.138

Open

$14.61

Previous Close

$14.12

Daily Range

$14.10 - $14.68

52-Week Range

$8.27 - $30.10

Estimated Earnings Date

Aug 11, 2026

Dividend

$0.00

Beta (Volatility)

1.87 (High)

Price

$14.11

Volume

467,357.138

Open

$14.61

Previous Close

$14.12

Daily Range

$14.10 - $14.68

52-Week Range

$8.27 - $30.10

Estimated Earnings Date

Aug 11, 2026

CLPT News

No articles available.

CLPT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About ClearPoint Neuro

ClearPoint Neuro helps doctors perform brain surgery with high precision. Its systems let surgeons see inside the brain using live scans. These tools help patients getting treatments for tumors or movement disorders.

Tools for the Brain

ClearPoint System: Integrated platform including a skull-mounted frame and software used to guide biopsy needles and electrodes into the brain.
SmartFlow Neuro Cannula: Injection tube designed to deliver gene and cell therapies directly to specific brain regions.
ClearPoint Prism: Laser therapy system used to heat and destroy soft tissue during brain procedures.
IRRAflow System: Automated platform that manages fluid and monitors pressure inside the head for critical care patients.
Navigation Software: Computer programs that help surgeons plan pathways and view instruments relative to brain anatomy.

Scaling Up the Business

Acquired IRRAS in 2025 to add neurocritical care products and fluid management tools to the portfolio.
Entered a multi-year license agreement with UCB in 2023 to develop delivery platforms for their gene therapy programs.
Released ClearPoint Navigation Software Version 3.0 in 2025 to support surgical procedures performed entirely in operating rooms.
Leased a new facility in 2025 to increase operational capacity for the preclinical services business.
Formed a partnership with NE Scientific in 2022 to add therapy modeling software to the company product line.

Precision in the Operating Room

ClearPoint stands out by combining real-time magnetic resonance imaging guidance with specialized tools for delivering complex drugs like gene therapies. Its expertise covers the entire cycle from early research testing to final surgical application in the hospital setting.

A Look at the Finances

Revenue reached $10.4 million in Q4 2025, up 34% from $7.8 million in Q4 2024.
Gross profit was $6.4 million in Q4 2025, up 34.5% year-over-year.
Net income was negative $7.8 million in Q4 2025, which deepened from a loss of $5.4 million in Q4 2024.
Free cash flow was negative $12.1 million in Q4 2025, worsened from negative $1.5 million in Q4 2024.

Evolution of ClearPoint

ClearPoint has transformed from a specialized imaging company into a broader neurosurgery business serving both hospitals and pharmaceutical partners. Recent moves into neurocritical care and operating room software show a strategy focused on expanding its surgical footprint.

AI Generated • May 8, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

172

CEO

Joseph Michael Burnett, MBA

Website

www.clearpointneuro.com

Headquarters

Solana Beach, CA 92075, US

CLPT Financials

Key Financial Metrics (TTM)

Gross Margin

61.82%

Operating Margin

-65.20%

Net Income Margin

-71.57%

Return on Equity

-140.96%

Return on Capital

-28.02%

Return on Assets

-31.11%

Earnings Yield

-7.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$423.45M

Shares Outstanding

29.99M

Volume

467.36K

Avg. Volume

715.61K

Financials (TTM)

Gross Profit

$25.11M

Operating Income

-$26.48M

EBITDA

-$23.66M

Operating Cash Flow

-$25.72M

Capital Expenditure

-$984.00K

Free Cash Flow

-$26.70M

Cash & ST Invst.

$35.59M

Total Debt

$63.59M

ClearPoint Neuro Performance Analysis

ClearPoint Neuro annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 20,551,000	26.1%
2023	2023-12-31	USD 23,955,000	16.6%
2024	2024-12-31	USD 31,390,000	31.0%
2025	2025-12-31	USD 36,971,000	17.8%

ClearPoint Neuro sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	8.6%
Q3	2025-09-30	-3.8%
Q4	2025-12-31	17.5%
Q1	2026-03-31	16.5%

ClearPoint Neuro annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -0.68	-2.2%
2023	2023-12-31	USD -0.90	32.1%
2024	2024-12-31	USD -0.70	-22.0%
2025	2025-12-31	USD -0.90	28.9%

ClearPoint Neuro sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2025-06-30	4.5%
Q3	2025-09-30	N/A
Q4	2025-12-31	-28.6%
Q1	2026-03-31	-18.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

$12.13M

+42.9%

Gross Profit

$7.55M

+47.1%

Gross Margin

62.24%

N/A

Market Cap

$423.45M

N/A

Market Cap/Employee

$2.46M

N/A

Employees

172

N/A

Net Income

-$9.55M

-58.5%

EBITDA

-$7.05M

-24.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

$35.59M

+187.3%

Total Debt

$63.59M

+1749.6%

Accounts Receivable

$8.66M

+137.3%

Inventory

$8.57M

+30.2%

Long Term Debt

$63.35M

+2115.2%

Short Term Debt

$234.00K

-59.5%

Return on Assets

-31.11%

N/A

Return on Invested Capital

-31.55%

N/A

Free Cash Flow

-$8.61M

-35.5%

Operating Cash Flow

-$7.97M

-29.1%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

OFIXOrthofix Medical Inc.

OFIXOrthofix Medical Inc.$11.25+2.65%

VREXVarex Imaging Corporation

VREXVarex Imaging Corporation$10.92+1.87%

AKBAAkebia Therapeutics, Inc.

AKBAAkebia Therapeutics, Inc.$1.22+0.00%

LABStandard BioTools Inc.

LABStandard BioTools Inc.$0.83-4.81%

SNDLSNDL Inc.

SNDLSNDL Inc.$1.25-0.40%

CTKBCytek Biosciences, Inc.

CTKBCytek Biosciences, Inc.$4.46-2.19%

SRDXSurmodics, Inc.

SRDXSurmodics, Inc.$42.98+0.35%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$92.32-0.08%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.46-0.01%

FFord Motor Company

FFord Motor Company$14.37+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

CLFCleveland-Cliffs

CLFCleveland-Cliffs$11.93+0.09%

Questions About CLPT

What is the current price of ClearPoint Neuro?

ClearPoint Neuro is trading at $14.12 per share.

What is the 52-week range for ClearPoint Neuro?

Over the past 52 weeks, ClearPoint Neuro has traded between $8.27 and $30.10.

How much debt does ClearPoint Neuro have?

As of the most recent reporting period, ClearPoint Neuro reported total debt of $63.59M.

How much cash does ClearPoint Neuro have on hand?

ClearPoint Neuro reported $35.59M in cash and cash equivalents in its most recent financial results.

What is ClearPoint Neuro’s dividend yield?

ClearPoint Neuro does not currently have a dividend yield.

ClearPoint Neuro(NASDAQ) CLPT

ClearPoint Neuro Financials at a Glance

CLPT News

CLPT: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About ClearPoint Neuro

Tools for the Brain

Scaling Up the Business

Precision in the Operating Room

A Look at the Finances

Evolution of ClearPoint

CLPT Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

ClearPoint Neuro Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About CLPT

What is the current price of ClearPoint Neuro?

What is the 52-week range for ClearPoint Neuro?

How much debt does ClearPoint Neuro have?

How much cash does ClearPoint Neuro have on hand?

What is ClearPoint Neuro’s dividend yield?

Premium Investing Services